General form of registration statement for all companies including face-amount certificate companies

CONSOLIDATED BALANCE SHEETS

v3.10.0.1
CONSOLIDATED BALANCE SHEETS - USD ($)
Jun. 30, 2018
Dec. 31, 2017
Dec. 31, 2016
Current assets:      
Cash $ 577,010 $ 11,342 $ 92,455
Accounts receivable, net 36,000 29,950
Prepaid expenses 1,139 13,210 8,400
Total current assets 614,149 54,502 100,855
Property and equipment, net 45,790 19,012 22,164
Other assets:      
Restricted cash   50,000
Intellectual property, net 250,000 251,963 279,729
Deposits, long term 13,422 13,422 17,634
Total other assets 263,422 265,385 347,363
Total assets 923,361 338,899 470,382
Current liabilities:      
Accounts payable and accrued expenses, including related party payables of $37,118 and $62,241, respectively 1,225,232 1,199,536 937,938
Deferred revenue, short term 236,648 237,347 432,836
Settlement payable 15,000 315,000
Convertible notes payable, short term, net of debt discount 2,753,791 87,033
Notes payable, net of debt discount, short term portion 246,337 172,748
Notes payable, net of debt discount, related party 186,590 186,590 210,761
Derivative liability   294,807
Total current liabilities 4,648,598 1,638,473 2,451,123
Long term debt:      
Deferred revenue, long term 284,347 401,346 613,428
Convertible notes payable, long term, net of debt discount 2,016,041 688,783
Warrant liability 175,975 26,903
Derivative liability   4,820,473
Total long term debt 284,347 2,593,362 6,149,587
Total liabilities 4,932,945 4,231,835 8,600,710
Commitments and contingencies (See Note 18)
Stockholders' deficit:      
Preferred stock value 16,000 16,000 16,000
Common stock, $0.001 par value; 750,000,000 shares authorized, 247,186,285 and 244,086,285 shares issued and outstanding as of June 30, 2018 and December 31, 2017, respectively 247,186 244,086 181,805
Common stock subscribed 1,250,000 100,000 100,000
Additional paid in capital 45,359,506 44,581,896 10,701,116
Accumulated deficit (50,887,847) (48,840,534) (19,134,865)
Total stockholders' deficit attributable to BioCorRx, Inc. (4,009,539) (3,892,936)  
Non-controlling interest (45)  
Total deficit (4,009,584) (3,892,936) (8,130,328)
Total liabilities and deficit 923,361 338,899 470,382
Series B Preferred Stock [Member]      
Stockholders' deficit:      
Preferred stock value $ 5,616 $ 5,616 $ 5,616